Alx Oncology Holdings (ALXO) Leases (2021 - 2026)

Alx Oncology Holdings' Leases history runs 6 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Leases fell 66.54% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 66.54% YoY), while the FY2025 annual figure was $1.5 million, down 62.18% from the prior year.
• Leases came in at $1.3 million for Q1 2026 at Alx Oncology Holdings, down from $1.5 million in the prior quarter.
• In the past five years, Leases ranged from a high of $6.1 million in Q2 2022 to a low of $600000.0 in Q1 2022.
• A 5-year average of $3.5 million and a median of $4.0 million in 2024 frame the typical range for Leases.
• On a YoY basis, Leases climbed as much as 805.5% in 2023 and fell as far as 80.56% in 2023.
• Alx Oncology Holdings' Leases stood at $5.6 million in 2022, then sank by 57.34% to $2.4 million in 2023, then surged by 66.67% to $4.0 million in 2024, then sank by 62.18% to $1.5 million in 2025, then declined by 15.8% to $1.3 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $1.3 million, $1.5 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison